Cas:4412-09-3 3,4-dichloro-2-[(3,4-dichloro-5-oxo-2H-furan-2-yl)oxy]-2H-furan-5-one manufacturer & supplier

We serve Chemical Name:3,4-dichloro-2-[(3,4-dichloro-5-oxo-2H-furan-2-yl)oxy]-2H-furan-5-one CAS:4412-09-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3,4-dichloro-2-[(3,4-dichloro-5-oxo-2H-furan-2-yl)oxy]-2H-furan-5-one

Chemical Name:3,4-dichloro-2-[(3,4-dichloro-5-oxo-2H-furan-2-yl)oxy]-2H-furan-5-one
CAS.NO:4412-09-3
Synonyms:Mucochloric anhydride;Caswell No. 584A;Muchloric anhydride;GC-2466
Molecular Formula:C8H2Cl4O5
Molecular Weight:319.91000
HS Code:2932209090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:498.4ºC at 760mmHg
Density:1.88g/cm3
Index of Refraction:1.606
PSA:61.83000
Exact Mass:317.86600
LogP:2.14720

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Mucochloric anhydride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,GC-2466 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Muchloric anhydride Use and application,Muchloric anhydride technical grade,usp/ep/jp grade.


Related News: AstraZeneca’s application for anifrolumab in SLE is under review by regulatory authorities in the US, EU and Japan, with decisions anticipated in the second half of 2021. Anifrolumab is not currently approved in any country. bromine nitrite manufacturers As of June’s end, there have been 100 reported GBS cases among J&J recipients, most of whom were hospitalized and one person has died, CDC officials reported. Most cases were seen in older men within 13 days following the single-dose vaccine. 1-amino-6-(2-methoxyphenyl)-2,7-dimethyl-3,8-dioxo-2,3,7,8-tetrahydro-2,7-naphthyridine-4-carbonitrile suppliers The little-known Italian company making the glass vials for most of the globe’s Covid-19 vaccines just scored a rare feat: a New York Stock Exchange IPO. It’s the biggest public offering for an Italian firm in the U.S. since Ferrari’s 2015 listing. α-(Anilino-benzyl)-phosphonsaeure-dibenzylester vendor & factory.